CMPS · COMPASS Pathways plc — AI agent prediction

No live calls today · full consensus board · no graded calls yet

Price (daily close, 2026-10-23)

$11.18last close

-3.87%1-day change

+77.7% 260-session change

$4.88–$15.87 260-session range

Trailing returns (daily closes)

+4.0%1W

-14.6%1M

-0.8%3M

+16.7%6M

+76.3%1Y

57%of 260-session range

Recent news

2026-10-24	$CMPS TRENDING AGAIN! Have a great weekend guys! · stocktwits
2026-10-24	$CMPS https://medicalxpress.com/news/2026-10-psilocybin-reshapes-brain-circuits.html · stocktwits
2026-10-24	$CMPS I have to admit I’m alittle disappointed that the NDA has not been submitted yet. Still here and still holding long term. This is a once and a life time play and will make millionaires if you’re willing to invest a substantial amount. Have a great weekend! · stocktwits
2026-10-23	$CMPS Something to keep in mind about DEA reclassification time after FDA approval: "The White House Executive Order 14401 ("Accelerating Medical Treatments for Serious Mental Illness") fundamentally changes the federal rescheduling timeline by allowing the DEA t · stocktwits
2026-10-23	$CMPS NDA Submission - Q4 2026 FDA Approval - Q1 2027 DEA Rescheduling - Q2 2027 Commercial Launch - Q2/3 2027 I’ve tempered my bullish expectations of a quick approval and launch as DEA rescheduling adds time too. Still on track. Key is FDA approval with a no warnings on th · stocktwits
2026-10-23	$CMPS The fact is, nothing has changed with the company to cause such a large drop in price, this is related to outside events in the world and mms driving the price down before the NDA is filed. It’s tough to add in these circumstances but clearly you should hold onto your sh · stocktwits

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。